Neurocrine Biosciences director George J. Morrow reports sale of $2.34 million in common shares
NBIX•Director George J. Morrow sold 15,000 Neurocrine Biosciences common shares from Oct. 30 through Nov. 3, 2026, and exercised options for 15,000 shares at $53.64 each. His direct holdings remained at 10,386 shares.
1. Share transactions
George J. Morrow sold 15,000 Neurocrine Biosciences common shares from Oct. 30 through Nov. 3, 2026. During the same period, he exercised non-qualified stock options for 15,000 common shares at $53.64 per share. His direct holdings remained at 10,386 shares after the transactions, and no options from the reported grant remained.
